JPH04504419A - - Google Patents

Info

Publication number
JPH04504419A
JPH04504419A JP50563890A JP50563890A JPH04504419A JP H04504419 A JPH04504419 A JP H04504419A JP 50563890 A JP50563890 A JP 50563890A JP 50563890 A JP50563890 A JP 50563890A JP H04504419 A JPH04504419 A JP H04504419A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50563890A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB898908250A priority Critical patent/GB8908250D0/en
Application filed filed Critical
Publication of JPH04504419A publication Critical patent/JPH04504419A/ja
Application status is Pending legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
JP50563890A 1989-04-12 1990-04-05 Pending JPH04504419A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB898908250A GB8908250D0 (en) 1989-04-12 1989-04-12 Formulations

Publications (1)

Publication Number Publication Date
JPH04504419A true JPH04504419A (en) 1992-08-06

Family

ID=10654880

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50563890A Pending JPH04504419A (en) 1989-04-12 1990-04-05

Country Status (7)

Country Link
EP (1) EP0467916A1 (en)
JP (1) JPH04504419A (en)
CA (1) CA2014401A1 (en)
GB (1) GB8908250D0 (en)
GR (1) GR900100280A (en)
PT (1) PT93739A (en)
WO (1) WO1990011754A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05255085A (en) * 1991-12-17 1993-10-05 Alfa Wassermann Spa Pharmaceutical preparation comprising rifaximin for treating vaginal infection
JP2011516612A (en) * 2008-04-15 2011-05-26 シェーリング コーポレイションSchering Corporation An oral pharmaceutical composition in a solid dispersion, preferably comprising posaconazole and HPMCAS

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK392592A3 (en) * 1990-06-29 1994-07-06 Fisons Plc Pressure aerosol composition
IL102130D0 (en) 1991-06-10 1993-01-14 Schering Corp Non-chlorofluorocarbon aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
PT631578E (en) * 1992-03-18 2001-11-30 Janssen Pharmaceutica Nv Stereoisomers of itraconazole and saperconazole
CA2154777A1 (en) * 1993-01-27 1994-08-04 Nancy M. Gray Method and composition employing (2r,4s) itraconazole
DE4323636A1 (en) * 1993-07-15 1995-01-19 Hoechst Ag Drug preparations of coated, heavy water-soluble drugs for inhalation dosage forms and methods for their preparation
JP2875140B2 (en) * 1993-08-16 1999-03-24 明治製菓株式会社 Anti-mrsa composition
NL1006103C2 (en) * 1997-05-21 1998-11-25 Nutricia Nv Spray on skin powder base.
CA2310687C (en) 1997-12-09 2004-08-17 The Goodyear Tire & Rubber Company Pneumatic tyre with an antenna for radio transponder
EP1039909B1 (en) 1997-12-31 2002-10-09 Choongwae Pharma Corporation Method of production and composition of an oral preparation of itraconazole
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
JP2004517127A (en) 2000-12-21 2004-06-10 ネクター セラピューティックス Pulmonary delivery of polyene antifungals
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
EP1789018A1 (en) * 2004-08-27 2007-05-30 The Dow Chemical Company Enhanced delivery of drug compositions to treat life threatening infections
EP2425820B1 (en) 2007-02-11 2015-04-08 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
WO2008124131A1 (en) * 2007-04-05 2008-10-16 The John Hopkins University Antifungal agents as neuroprotectants
EP2601973A1 (en) 2011-12-09 2013-06-12 Laboratoires SMB SA Dry powder formulation of azole derivative for inhalation
WO2014106727A1 (en) 2013-01-03 2014-07-10 Vectura Limited Inhaler and formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1241602A (en) * 1984-02-23 1988-09-06 Ortho Pharmaceutical Corporation Antifungal aerosol solution
JPH01153634A (en) * 1987-12-10 1989-06-15 Kyorin Pharmaceut Co Ltd Absorbing agent

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05255085A (en) * 1991-12-17 1993-10-05 Alfa Wassermann Spa Pharmaceutical preparation comprising rifaximin for treating vaginal infection
JP2011516612A (en) * 2008-04-15 2011-05-26 シェーリング コーポレイションSchering Corporation An oral pharmaceutical composition in a solid dispersion, preferably comprising posaconazole and HPMCAS
JP2014139230A (en) * 2008-04-15 2014-07-31 Merck Sharp & Dohme Corp Oral pharmaceutical composition in solid dispersion comprising preferably posaconazole and hpmcas

Also Published As

Publication number Publication date
PT93739A (en) 1990-11-20
GR900100280A (en) 1991-09-27
EP0467916A1 (en) 1992-01-29
CA2014401A1 (en) 1990-10-12
GB8908250D0 (en) 1989-05-24
WO1990011754A1 (en) 1990-10-18

Similar Documents

Publication Publication Date Title
DE8900751U1 (en)
DE8900975U1 (en)
DE4090195T (en)
DE8900659U1 (en)
DE8900915U1 (en)
DE8901078U1 (en)
DE8901286U1 (en)
DE8900127U1 (en)
DE8900606U1 (en)
DE8900142U1 (en)
DE8900205U1 (en)
DE8900442U1 (en)
DE8900283U1 (en)
DE4092221T1 (en)
DE8900278U1 (en)
DE8900312U1 (en)
AU2632488A (en)
DE8900305U1 (en)
DE8900609U1 (en)
DE4091571T (en)
DE8900145U1 (en)
DE8901185U1 (en)
DE4091278D2 (en)
DE8901171U1 (en)
DE8901029U1 (en)